Objective: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease in obese youth. Lifestyle intervention was demonstrated to improve NAFLD but follow-up studies after end of intervention are lacking. Furthermore the necessary degree of overweight reduction for improvement of NAFLD remains unknown.
Methods: We examined standard deviation score of body mass index (SDS-BMI) and transaminases in 152 obese children with NAFLD diagnosed by ultrasound at baseline, at the end of a 1-year intervention and 2 years after baseline. Within-subject changes of these parameters were compared by participation in the intervention based on physical activity, nutrition education and behaviour therapy.
Results: In contrast to 43 children without lifestyle intervention, participation in lifestyle intervention (n = 109) was associated with a significant decrease of transaminases and overweight 1 and 2 years after baseline (1 year: alanine transaminase (ALT) −10 U/l (−14 to −6); aspartate transaminase (AST) −5 U/l (−7 to −3); SDS-BMI −0.23 (−0.30 to −0.16); 2 years: ALT −9 U/l (−12 to −6); AST −6 U/l (−7 to −4); SDS-BMI −0.30 (−0.37 to −0.22); data as mean changes and 95% confidence interval compared to baseline). Any degree of overweight reduction was associated with a significant decrease of NAFLD prevalence. The greatest decrease of NAFLD prevalence (1 year: −89% (95% CI −72% to −100%); 2 years: −94% (95% CI −83% to −100%)) was observed in children with the greatest overweight reduction (SDS-BMI decrease >0.5).
Conclusions: Multidisciplinary lifestyle intervention is effective to improve NAFLD even in the 1-year follow-up after the end of intervention. A minimal reduction of overweight led to an improvement of NAFLD.
Trial registration number: NCT00435734.
Statistics from Altmetric.com
Funding: Grant support from of the German “Competence Net Obesity”, which is supported by the German Federal Ministry of Education and Research (grant number 01 GI0839).
Competing interests: None.
Ethics approval: The study was approved by the local ethics committee of the University of Witten-Herdecke.
Patient consent: Obtained.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.